Paolo Fundaro's most recent trade in Intercept Pharmaceuticals Inc was a trade of 12,547 Option to Purchase Common Stock done . Disclosure was reported to the exchange on May 24, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intercept Pharmaceuticals Inc | Paolo Fundaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 12,547 | 12,547 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Paolo Fundaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 8,111 | 43,905 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Paolo Fundaro | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 12,790 | 12,790 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Paolo Fundaro | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 7,737 | 35,794 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Paolo Fundaro | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 12,089 | 12,089 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Paolo Fundaro | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,029 | 28,057 (0%) | 0% | 0 | Common Stock |